Innovis Asset Management’s Pfizer PFE Stock Holding History

Innovis Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$482K	Buy	14,525 +405	+3%	+$14.3K	0.19%	68
2023 Q2	$518K	Sell	14,120 -136,610	-91%	-$5.32M	0.19%	69
2023 Q1	$6.15M	Sell	150,730 -3,990	-3%	-$172K	2.49%	10
2022 Q4	$7.93M	Buy	+154,720	New	+$7.42M	3.58%	4

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Innovis Asset Management's PFE Position: Q3 2023 in Review

Innovis Asset Management increased its Pfizer (PFE) stake by 2.9% in Q3 2023, buying an estimated $14.3K and bringing the position to 14,525 shares worth $482K. The position accounts for 0.19% of the portfolio, ranked #68.

Innovis Asset Management first reported a position in PFE in Q4 2022 and has held it in 4 quarters since. The position peaked at $7.93M in Q4 2022. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Innovis Asset Management held 14,525 shares of Pfizer worth $482K as of Q3 2023.
Innovis Asset Management bought 405 Pfizer shares in Q3 2023, an estimated $14.3K.
Pfizer made up 0.19% of Innovis Asset Management's portfolio in Q3 2023, its #68 holding.
Innovis Asset Management first reported a position in Pfizer in Q4 2022 and has held it in 4 quarters since.
Innovis Asset Management's Pfizer position peaked at $7.93M in Q4 2022.
2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.